Legence Corp. LGN
32.05 USD -0.11 (-0.34%)
At closeNov 10, 2026, 4:01 PM EST
32.05 0.00 0.00%
After hours · Nov 10, 4:01 PM ET
30.50 Day range 33.13
23.90 52-week range 107.24
- YTD
- -25.53%
- 1 year
- -12.38%
News
defenseworld.net LGN (NASDAQ:LGN) versus IES (NASDAQ:IESC) Critical Review IES (NASDAQ: IESC - Get Free Report) and LGN (NASDAQ: LGN - Get Free Report) are both mid-cap industrials companies, but which is the better business? We will contrast the two companies based on the…
benzinga.com Barclays Maintains Equal-Weight on Legence, Lowers Price Target to $60 Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and lowers the price target from $80 to $60.
benzinga.com RBC Capital Maintains Outperform on Legence, Lowers Price Target to $90 RBC Capital analyst Sabahat Khan maintains Legence (NASDAQ:LGN) with a Outperform and lowers the price target from $101 to $90.- benzinga.com Stifel Maintains Buy on Legence, Lowers Price Target to $82 Stifel analyst Brian Brophy maintains Legence (NASDAQ:LGN) with a Buy and lowers the price target from $101 to $82.
benzinga.com Legence Reports Q2 2026 Results: Full Earnings Call Transcript On Thursday, Legence (NASDAQ:LGN) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For…
benzinga.com Tigress Financial Maintains Buy on Legence, Raises Price Target to $130 Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $125 to $130.
benzinga.com B of A Securities Maintains Buy on Legence, Raises Price Target to $116 B of A Securities analyst Sherif El-Sabbahy maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $105 to $116.
benzinga.com These Analysts Revise Their Forecasts On Legence Following Q2 Results Legence Corp (NASDAQ: LGN) reported mixed Q2 results, missing earnings estimates but beating sales expectations. Analysts lowered price targets.
benzinga.com BMO Capital Maintains Outperform on Legence, Raises Price Target to $105 BMO Capital analyst Devin Dodge maintains Legence (NASDAQ:LGN) with a Outperform and raises the price target from $100 to $105.
benzinga.com BTIG Reiterates Buy on Legence, Lowers Price Target to $100 BTIG analyst Gregory Lewis reiterates Legence (NASDAQ:LGN) with a Buy and lowers the price target from $120 to $100.- benzinga.com Legence Q2 EPS $0.17 Misses $0.33 Estimate, Sales $1.260B Beat $1.074B Estimate Legence (NASDAQ:LGN) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.33 by 48.48 percent. The company reported quarterly sales of $1.260 billion which…
benzinga.com Legence Raises FY2026 Sales Guidance from $4.100B-$4.300B to $4.700B-$4.800B vs $4.274B Est Legence (NASDAQ:LGN) raises FY2026 sales outlook from $4.100 billion-$4.300 billion to $4.700 billion-$4.800 billion vs $4.274 billion estimate.- benzinga.com RBC Capital Maintains Outperform on Legence, Lowers Price Target to $101 RBC Capital analyst Sabahat Khan maintains Legence (NASDAQ:LGN) with a Outperform and lowers the price target from $106 to $101.
- benzinga.com Guggenheim Maintains Buy on Legence, Raises Price Target to $115 Guggenheim analyst Joseph Osha maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $106 to $115.
- benzinga.com Barclays Maintains Equal-Weight on Legence, Raises Price Target to $80 Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and raises the price target from $60 to $80.
- benzinga.com Tigress Financial Maintains Buy on Legence, Raises Price Target to $125 Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $85 to $125.
- benzinga.com Barclays Maintains Equal-Weight on Legence, Raises Price Target to $60 Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and raises the price target from $45 to $60.
- benzinga.com BMO Capital Maintains Outperform on Legence, Raises Price Target to $100 BMO Capital analyst Devin Dodge maintains Legence (NASDAQ:LGN) with a Outperform and raises the price target from $63 to $100.
- benzinga.com BTIG Maintains Buy on Legence, Raises Price Target to $120 BTIG analyst Gregory Lewis maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $75 to $120.
benzinga.com Legence Q1 2026 Earnings Call Transcript 
benzinga.com Legence Stock Retreats Despite Triple-Digit Revenue Growth And Raised Outlook Legence (NASDAQ: LGN) shares reversed Thursday, turning lower despite Q1 revenue beat, above-estimate Q2 guidance and raised FY26 outlook.
benzinga.com Earnings Scheduled For May 14, 2026 - benzinga.com Legence Raises FY2026 Sales Guidance from $3.700B-$3.900B to $4.100B-$4.300B vs $3.886B Est Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.700 billion-$3.900 billion to $4.100 billion-$4.300 billion vs $3.886 billion estimate.
- benzinga.com Legence Q1 EPS $0.13 Misses $0.21 Estimate, Sales $1.038B Beat $930.098M Estimate Legence (NASDAQ:LGN) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.21 by 38.1 percent. The company reported quarterly sales of $1.038 billion which…
benzinga.com S&P 500 Hits Another Record High: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone CNN Business Fear & Greed Index measures market sentiment with a range of 0-100. Its reading of 65.8 on Wed indicated Greed despite slight improvement.
benzinga.com Dillard's, Cisco Systems And 3 Stocks To Watch Heading Into Thursday U.S. stock futures up, Dillard's, Cisco, Applied Materials, Doximity, Legence expected to report earnings. Stocks to watch. Photo via Shutterstock.
benzinga.com This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.- benzinga.com Loop Capital Initiates Coverage On Legence with Buy Rating, Announces Price Target of $96 Loop Capital analyst Jeffrey Stevenson initiates coverage on Legence (NASDAQ:LGN) with a Buy rating and announces Price Target of $96.
- benzinga.com GLJ Research Initiates Coverage On Legence with Buy Rating, Announces Price Target of $99 GLJ Research analyst Austin Wang initiates coverage on Legence (NASDAQ:LGN) with a Buy rating and announces Price Target of $99.
- benzinga.com Tigress Financial Maintains Buy on Legence, Raises Price Target to $85 Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $60 to $85.
benzinga.com Goldman Sachs Maintains Buy on Legence, Raises Price Target to $72 Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $63 to $72.- benzinga.com Legence Says Selling Stockholders Affiliated With Blackstone Intend To Offer And Sell 11M Shares Of Legence's Class A Common Stock In Secondary Underwritten Public Offering Legence Corp. (NASDAQ:LGN) ("Legence" or the "Company") today announced that selling stockholders affiliated with Blackstone Inc. (the "Selling Stockholders") intend to offer and sell 11,000,000…
benzinga.com 5 Stock Picks Last Week From Wall Street's Most Accurate Analysts Stock market mixed on Trump comments and Iran drafting monitoring protocol for Strait of Hormuz. Benzinga's Analyst Ratings API provides top analyst picks and their accuracy to help traders beat the…
benzinga.com 5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month US stocks up on Trump's Iran comments, but March saw losses. Benzinga's Analyst Ratings API offers data to predict market movements, see top analyst picks.- benzinga.com Goldman Sachs Maintains Buy on Legence, Raises Price Target to $63 Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $52 to $63.
- benzinga.com RBC Capital Maintains Outperform on Legence, Raises Price Target to $64 RBC Capital analyst Sabahat Khan maintains Legence (NASDAQ:LGN) with a Outperform and raises the price target from $48 to $64.
benzinga.com Legence Analysts Boost Their Forecasts After Q4 Results Legence Corp. reported mixed Q4 results, with earnings missing estimates but sales beating expectations. FY2026 sales guidance also raised.
benzinga.com Expedia To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Monday Top analysts changed ratings for OVV, ALMS, CLMT, LGN, RCKT, UTHR, VNT, HOOD. See full changes at benzinga.com/analyst-stock-ratings- benzinga.com Guggenheim Maintains Buy on Legence, Raises Price Target to $74 Guggenheim analyst Joseph Osha maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $68 to $74.
- benzinga.com BMO Capital Maintains Outperform on Legence, Raises Price Target to $63 BMO Capital analyst Devin Dodge maintains Legence (NASDAQ:LGN) with a Outperform and raises the price target from $46 to $63.
- benzinga.com 12 Industrials Stocks Moving In Friday's Pre-Market Session
- benzinga.com Legence Raises FY2026 Sales Guidance from $3.500B-$3.700B to $3.700B-$3.900B Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.500 billion-$3.700 billion to $3.700 billion-$3.900 billion.
- benzinga.com Earnings Scheduled For March 27, 2026
benzinga.com Legence Q4 EPS $(0.55) Misses $0.02 Estimate, Sales $737.642M Beat $620.307M Estimate Legence (NASDAQ:LGN) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $0.02 by 2391.67 percent. The company reported quarterly sales of $737.642 million…
benzinga.com Carnival, Unity Software And 3 Stocks To Watch Heading Into Friday Stock futures mixed, investors may focus on Legence Corp, Unity Software, Carnival Corp, Argan Inc and SBC Medical Group Holdings earnings.
benzinga.com Nasdaq Dips Over 500 Points As Iran Rejects Ceasefire: Fear & Greed Index Remains In 'Extreme Fear' Zone Stocks fall due to rising oil prices and failed Iran talks. Fear & Greed Index shows slight increase in fear level.- benzinga.com Guggenheim Maintains Buy on Legence, Raises Price Target to $68 Guggenheim analyst Joseph Osha maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $53 to $68.
benzinga.com RingCentral Posts Upbeat Q4 Earnings, Joins Tandem Diabetes, AXT, Opendoor Technologies And Other Big Stocks Moving Higher On Friday - benzinga.com Goldman Sachs Maintains Buy on Legence, Raises Price Target to $52 Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $46 to $52.
- benzinga.com Stifel Maintains Buy on Legence, Raises Price Target to $58 Stifel analyst Brian Brophy maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $50 to $58.